Ouyang, M.J.; Ao, Z.; Olukitibi, T.A.; Lawrynuik, P.; Shieh, C.; Kung, S.K.P.; Fowke, K.R.; Kobasa, D.; Yao, X.
Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses. Vaccines 2023, 11, 1404.
https://doi.org/10.3390/vaccines11091404
AMA Style
Ouyang MJ, Ao Z, Olukitibi TA, Lawrynuik P, Shieh C, Kung SKP, Fowke KR, Kobasa D, Yao X.
Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses. Vaccines. 2023; 11(9):1404.
https://doi.org/10.3390/vaccines11091404
Chicago/Turabian Style
Ouyang, Maggie Jing, Zhujun Ao, Titus A. Olukitibi, Peter Lawrynuik, Christopher Shieh, Sam K. P. Kung, Keith R. Fowke, Darwyn Kobasa, and Xiaojian Yao.
2023. "Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses" Vaccines 11, no. 9: 1404.
https://doi.org/10.3390/vaccines11091404
APA Style
Ouyang, M. J., Ao, Z., Olukitibi, T. A., Lawrynuik, P., Shieh, C., Kung, S. K. P., Fowke, K. R., Kobasa, D., & Yao, X.
(2023). Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses. Vaccines, 11(9), 1404.
https://doi.org/10.3390/vaccines11091404
